These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 25343081)

  • 1. Dry age-related macular degeneration: A currently unmet clinical need.
    Girmens JF; Sahel JA; Marazova K
    Intractable Rare Dis Res; 2012 Aug; 1(3):103-14. PubMed ID: 25343081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in the management of dry age-related macular degeneration: A review.
    Bandello F; Sacconi R; Querques L; Corbelli E; Cicinelli MV; Querques G
    F1000Res; 2017; 6():245. PubMed ID: 28529701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current drug and molecular therapies for the treatment of atrophic age-related macular degeneration: phase I to phase III clinical development.
    Li H; Chintalapudi SR; Jablonski MM
    Expert Opin Investig Drugs; 2017 Oct; 26(10):1103-1114. PubMed ID: 28816076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-related macular degeneration: diagnosis and management.
    Cook HL; Patel PJ; Tufail A
    Br Med Bull; 2008; 85():127-49. PubMed ID: 18334518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dry Age-Related Macular Degeneration Pharmacology.
    Wright CB; Ambati J
    Handb Exp Pharmacol; 2017; 242():321-336. PubMed ID: 27900609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on geographic atrophy in age-related macular degeneration.
    Biarnés M; Monés J; Alonso J; Arias L
    Optom Vis Sci; 2011 Jul; 88(7):881-9. PubMed ID: 21532519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of Neovascular Age-related Macular Degeneration: A Review on Landmark Randomized Controlled Trials.
    Agarwal A; Aggarwal K; Gupta V
    Middle East Afr J Ophthalmol; 2016; 23(1):27-37. PubMed ID: 26957836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging Treatment Options for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration.
    Khan H; Aziz AA; Sulahria H; Khan H; Ahmed A; Choudhry N; Narayanan R; Danzig C; Khanani AM
    Clin Ophthalmol; 2023; 17():321-327. PubMed ID: 36741078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drugs in Phase II clinical trials for the treatment of age-related macular degeneration.
    Tolentino MJ; Dennrick A; John E; Tolentino MS
    Expert Opin Investig Drugs; 2015 Feb; 24(2):183-99. PubMed ID: 25243494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developing Therapies for Age-related Macular Degeneration: The Art and Science of Problem-solving: The 2018 Charles L. Schepens, MD, Lecture.
    Miller JW
    Ophthalmol Retina; 2019 Oct; 3(10):900-909. PubMed ID: 31585712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current therapeutic developments in atrophic age-related macular degeneration.
    Hanus J; Zhao F; Wang S
    Br J Ophthalmol; 2016 Jan; 100(1):122-7. PubMed ID: 26553922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of non-neovascular age-related macular degeneration on face recognition performance.
    Taylor DJ; Smith ND; Binns AM; Crabb DP
    Graefes Arch Clin Exp Ophthalmol; 2018 Apr; 256(4):815-821. PubMed ID: 29484559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Treatments for Age-Related Macular Degeneration: A Review of Clinical Advances in Sustained Drug Delivery Systems.
    Jiménez-Gómez Y; Alba-Molina D; Blanco-Blanco M; Pérez-Fajardo L; Reyes-Ortega F; Ortega-Llamas L; Villalba-González M; Fernández-Choquet de Isla I; Pugliese F; Stoikow I; González-Andrades M
    Pharmaceutics; 2022 Jul; 14(7):. PubMed ID: 35890368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene, Cell and Antibody-Based Therapies for the Treatment of Age-Related Macular Degeneration.
    Akyol E; Lotery A
    Biologics; 2020; 14():83-94. PubMed ID: 32982165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What Does Genetics Tell Us About Age-Related Macular Degeneration?
    Grassmann F; Ach T; Brandl C; Heid IM; Weber BHF
    Annu Rev Vis Sci; 2015 Nov; 1():73-96. PubMed ID: 28532374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD).
    Ramkumar HL; Zhang J; Chan CC
    Prog Retin Eye Res; 2010 May; 29(3):169-90. PubMed ID: 20206286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges in the Development of Therapy for Dry Age-Related Macular Degeneration.
    Wei CX; Sun A; Yu Y; Liu Q; Tan YQ; Tachibana I; Zeng H; Wei JY
    Adv Exp Med Biol; 2016; 854():103-9. PubMed ID: 26427400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of age-related macular degeneration and therapeutic opportunities.
    van Lookeren Campagne M; LeCouter J; Yaspan BL; Ye W
    J Pathol; 2014 Jan; 232(2):151-64. PubMed ID: 24105633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Choriocapillaris changes in dry age-related macular degeneration and geographic atrophy: a review.
    Arya M; Sabrosa AS; Duker JS; Waheed NK
    Eye Vis (Lond); 2018; 5():22. PubMed ID: 30238015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Progression of treatment and researches in dry age related macular degeneration].
    Zhang K; Tang S
    Zhonghua Yan Ke Za Zhi; 2015 Mar; 51(3):236-40. PubMed ID: 26268648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.